AXSM
NASDAQ · Pharmaceuticals
Axsome Therapeutics Inc
$129.80
-7.20 (-5.26%)
Performance
1D
—
1W
-10.13%
1M
-24.96%
3M
-41.24%
6M
-40.04%
1Y
-6.89%
YTD
-27.36%
Open$137.00
Previous Close$137.00
Day High$137.56
Day Low$128.99
52W High$260.19
52W Low$123.50
Volume—
Avg Volume879.2K
Market Cap7.57B
P/E Ratio—
EPS$-3.76
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$180.64
Below
SMA 200
$198.71
Below
RSI (14)
21.9
Oversold
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
28 analysts
Price Target
-49.1% upside
Current
$129.80
$129.80
Target
$66.03
$66.03
$47.60
$66.03 avg
$88.20
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 672.62M | 1.74B | 1.62B |
| Net Income | -192,964,882 | 523.27M | 458.37M |
| Profit Margin | -28.7% | 30.1% | 28.3% |
| EBITDA | -179,900,016 | 948.73M | 868.54M |
| Free Cash Flow | — | 423.20M | 592.85M |
| Rev Growth | +133.7% | -6.3% | -6.3% |
| Debt/Equity | 3.25 | 0.60 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,364.73 | -3.76% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $272.32 | -1.45% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $146.94 | -2.27% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.88 | -2.96% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $63.13 | -1.65% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $82.11 | -7.95% | 12.3 | 32.24B |